Granulocyte colony-stimulating factor (G-CSF) receptor gene expression of ovarian carcinoma does not correlate with G-CSF caused cell proliferation

Cancer

Volumn 91, Issue 7, 2001, Pages 1372-1383

  Brandstetter, Thomas ^a,e   Ninci, Elena ^b   Bettendorf, Herta ^a   Perewusnyk, Gloria ^b   Stolte, Jens ^c   Herchenbach, Dieter ^d   Sellin, Dieter ^b   Wagner, Edgar ^b   Köchli, Ossi R ^e   Bauknecht, Thomas ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

^b UNIVERSITY OF FREIBURG   (Germany)

^c UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^d Practice for Pathology ^*  (Germany)

^e UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

ATP viability assay; Granulocyte colony stimulating factor receptor; Ovarian carcinoma; Proliferation

Indexed keywords

GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE COLONY STIMULATING FACTOR RECEPTOR;

ARTICLE; CELL PROLIFERATION; CORRELATION FUNCTION; DIAGNOSTIC VALUE; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; OVARY CARCINOMA; PRIORITY JOURNAL;

ADENOSINE TRIPHOSPHATE; BIOPSY; BLOTTING, SOUTHERN; CARCINOMA; CELL DIVISION; COLONY-STIMULATING FACTORS, RECOMBINANT; FEMALE; GENE EXPRESSION; GRANULOCYTE COLONY-STIMULATING FACTOR; HUMANS; IMMUNOHISTOCHEMISTRY; OVARIAN NEOPLASMS; RECEPTORS, GRANULOCYTE COLONY-STIMULATING FACTOR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TUMOR CELLS, CULTURED;

EID: 0035312452     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/1097-0142(20010401)91:7<1372::AID-CNCR1141>3.0.CO;2-E     Document Type: Article

References (50)

1. In vitro growth effects of colony-stimulating factors in ovarian cancer
2. G-CSF production in human bladder cancer and its ability to promote autocrine growth: A review
3. Constitutive production of multiple cytokines and a human chorionic gonadotrophin beta-subunit by a human bladder cancer cell line (KU-19-19): Possible demonstration of totipotential differentiation
4. Granulocyte colony-stimulating factor produced by bladder carcinoma of a patient with leukemoid reaction did not affect proliferation of the tumor cells
5. c-jun expression and growth stimulation in human ovarian carcinoma cell lines following exposure to cytokines
6. Granulocyte-colony stimulating factor, granulocyte-macrophage colony stimulating factor and interleukin 4 induce differentiation in the U-937 human monocytic leukemia cell line
7. Granulocyte colony-stimulating factor on the growth of human ovarian carcinoma cells in vitro
8. rhG-CSF affects genes involved in mitogen signalling and early gene expression in the ovarian cancer cell line HEY
9. G-CSF receptor expression in ovarian cancer
10. Distinct cytoplasmic regions of the human granulocyte colony-stimulating factor involved in induction of proliferation and maturation
11. Growth and differentiation signals mediated by the cytoplasmic domain of granulocyte colony-stimulating factor receptor
12. Multiple signaling pathways induced by granulocyte colony-stimulating factor involving activation of JAKs, STAT5, and/or STAT3 are required for regulation of three distinct classes of immediate early genes
13. A point mutation in the granulocyte colony-stimulating factor receptor (G-CSF-R) gene in a case of acute myeloid leukemia results in the overexpression of a novel G CSF-R isoform
14. Phosphorylation of c-jun mediated by MAP kinases
15. Ras/MAP kinase signalling pathway
16. Identification of an oncoprotein- and UV-response protein kinase that binds and potentiates the c-Jun activation domain
17. Tumor necrosis factor alpha stimulates AP-1 activity through prolonged activation of the c-Jun kinase
18. A case of ovarian carcinoma with production of granulocyte colony-stimulating factor
19. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction
20. Three different mRNAs encoding human granulocyte colony-stimulating factor receptor
21. ATP-cell viability assay methodology in both fresh gynecologic tumors and cell lines
22. Application of a bioluminescence assay in human tumor chemosensitivity testing
23. Recombinant human granulocyte-macrophage colony-stimulating factor induces secretion of autoinhibitory monokines by U-937 cells
24. Specific involvement of tyrosine 764 of human granulocyte-stimulating factor receptor in signal transduction mediated by p145/Shc/GRB2 or p90/GRB2 complexes
25. Integration of MAP kinase signal transduction pathways at serum response element
26. Chemosensitivitätstestung in der gynäkologischen onkologie
27. Evaluation of new drugs an combinations in gynecologic tumors and cancer cell lines with the ATP-cell viability assay
28. In vitro potentiation of radiation cytotoxicity by recombinant interferons in cervical cancer cell lines
29. Direct and indirect effects of recombinant human granulocyte-colony stimulating factor on in vitro colony formation of human bladder cancer cells
30. G-CSF production in human bladder cancer and its ability to promote autocrine growth: A review
31. Human granulocyte colony-stimulating factor: Biologic activities and receptor characterization on hematopoietic cells and small cell lung cancer cell lines
32. Identification and characterization of receptors for granulocyte colony-stimulating factor on human placenta and trophoblastic cells
33. Granulocyte- and granulocyte-macrophage-colony stimulating factors induce human endothelial cells to migrate and proliferate
34. A novel family of growth factor receptors: A common binding domain in the growth hormone, prolactin, erythropoietin and IL-6 receptors, and the p75 IL-2 receptor beta-chain
35. Granulocyte-colony-stimulating factor enhances invasive potential of human head-and-neck-carcinoma cell lines
36. G-CSF increases secretion of urokinase-type plasminogen activator by human lung cancer cells
37. Defective internalization and sustained activation of truncated granulocyte colony-stimulating factor receptor found in severe congenital neutropenia/acute myeloid leukemia
38. Deletion of a critical internalization domain in the G-CSFR in acute myelogenous leukemia preceded by severe congenital neutropenia
39. Pharmacokinetic and pharmacodynamic analysis of subcutaneous recombinant human granulocyte colony stimulating factor (lenograstim) administration
40. A Phase I study of continuous infusion doxorubicin and paclitaxel chemotherapy with granulocyte colony-stimulating factor for relapsed epithelial ovarian cancer
41. Phase I and pharmacologic study of the combination of paclitaxel, cisplatin, and topotecan administered intravenously every 21 days as first-line therapy in patients with advanced ovarian cancer
42. A phase II double-blind randomized study of the simultaneous administration of recombinant human interleukin-6 and recombinant human granulocyte colony-stimulating factor following paclitaxel and carboplatin chemotherapy in patients with advanced epithelial ovarian cancer
43. Growth factors and cancer
44. Molecular characterization and chromosomal mapping of melanoma growth stimulatory activity, a growth factor structurally related to beta-thromboglobulin
45. Immunohistochemical localization of gastrin-releasing peptide in normal and diseased human lung
46. Expression cloning of a human granulocyte colony-stimulating factor receptor: A structural mosaic of hematopoietin receptor, immunoglobulin, and fibronectin domains
47. Chromosomal gene organization of the human granulocyte colony-stimulating factor receptor
48. Granulocyte colony-stimulating factor rapidly activates a distinct STAT-like protein in normal myeloid cells
49. Expression of ras oncogenes-in cultured human cells alters the transcriptional and posttranscriptional regulation of cytokines genes
50. An in vivo model to compare human leukocyte infiltration in carcinoma xenografts producing different chemokines